Table 11.8

Adjusted Graft Survival, Heart Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 4,130 91.3% 0.4% 4,130 86.9% 0.5% 8,460 79.2% 0.5% 12,889 71.9% 0.5%
Primary Diagnosis Coronary Artery Disease 1,753 91.4% 0.7% 1,753 86.8% 0.9% 3,639 78.9% 0.8% 5,674 71.7% 0.8%
Cardiomyopathy 1,899 92.7% 0.6% 1,899 88.4% 0.8% 3,880 81.9% 0.7% 5,840 74.0% 0.7%
Congenital Heart Disease 354 83.4% 2.6% 354 78.9% 3.0% 684 67.6% 2.6% 987 61.7% 2.4%
Valvular Heart Disease 92 90.7% 2.9% 92 88.6% 3.2% 202 74.3% 3.3% 293 70.8% 3.3%
Other 18 83.6% 8.2% 18 72.6% 10.0% 29 61.4% 11.1% 47 57.2% 8.9%
Unknown 14 92.4% 7.0% 14 84.8% 9.5% 26 69.9% 10.8% 48 55.9% 9.1%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.